Symbols / AUVI $0.00 +0.00% Applied UV, Inc.
AUVI Chart
About
Applied UV, Inc., through its subsidiaries, acquires, develops, markets, and sells proprietary surface and air disinfection technology products in the United States and internationally. The company focuses on indoor air quality products, specialty LED lighting products, luxury mirrors, and commercial furnishings. It also offers custom luxury and backlit mirrors, and conference room and living spaces furnishings. The company serves healthcare, commercial and public venue, hospitality, food preservation, cannabis, education, and winery markets. Applied UV, Inc. was incorporated in 2019 and is headquartered in Mount Vernon, New York.
Fundamentals
Scroll to Statements| Sector | Consumer Cyclical | Industry | Furnishings, Fixtures & | Market Cap | 1.87K |
| Enterprise Value | 11.46M | Income | -14.82M | Sales | 40.72M |
| Book/sh | 11.98 | Cash/sh | 0.26 | Dividend Yield | — |
| Payout | 0.00% | Employees | 131 | IPO | — |
| P/E | — | Forward P/E | — | PEG | — |
| P/S | 0.00 | P/B | 0.00 | P/C | — |
| EV/EBITDA | -1.13 | EV/Sales | 0.28 | Quick Ratio | 0.30 |
| Current Ratio | 0.61 | Debt/Eq | 31.41 | LT Debt/Eq | — |
| EPS (ttm) | -40.00 | EPS next Y | — | EPS Growth | — |
| Revenue Growth | 55.50% | Earnings | 2023-05-22 16:00 | ROA | -17.97% |
| ROE | -62.70% | ROIC | — | Gross Margin | 19.22% |
| Oper. Margin | -56.88% | Profit Margin | -32.43% | Shs Outstand | 4.67M |
| Shs Float | 4.27M | Short Float | 1.94% | Short Ratio | 0.45 |
| Short Interest | — | 52W High | 0.01 | 52W Low | 0.00 |
| Beta | 13.15 | Avg Volume | 1.30K | Volume | 1.17K |
| Target Price | — | Recom | None | Prev Close | $0.00 |
| Price | $0.00 | Change | 0.00% |
Valuation Models
Price estimates from analyst targets and simple models.
Ratings
- AUVI Stock Price, News & Analysis - Stock Titan Fri, 25 Apr 2025 01
- Aurora Innovation stock jumps 10% premarket as Amazon AWS, Aumovio deal spotlights driverless trucks - TechStock² Wed, 07 Jan 2026 08
- Applied UV (AUVI) Stock Pops on Acquisitions News - InvestorPlace ue, 20 Dec 2022 08
- Applied Uv Stock Price Forecast. Should You Buy AUVI? - StockInvest.us Fri, 04 Dec 2020 13
- Walgreens to offer Auvi-Q as EpiPen shortage challenges parents - CNBC hu, 06 Sep 2018 07
- As Survey Finds Majority Struggling to Find EpiPens, Rival Auvi-Q Gains - Allergic Living hu, 16 Aug 2018 07
- Amid EpiPen shortage, Kaléo strikes Walgreens pact to stock competitor nationwide - Fierce Pharma hu, 06 Sep 2018 07
- Walgreens to stock EpiPen alternative - Houston Chronicle hu, 06 Sep 2018 07
- Applied UV Stock Price, News, Quote & History - Investing News Network Fri, 14 Apr 2023 02
- Applied UV Files for Chapter 11 Bankruptcy Protection - inside.lighting Mon, 03 Jun 2024 07
- EpiPen Competitor Auvi-Q To Return To Market, Promising Lower Costs For Patients - Forbes Wed, 26 Oct 2016 07
- EpiPen Shortage Causes Many To Turn To Auvi-Q As Alternative - CBS News Mon, 20 Aug 2018 07
- Mylan’s EpiPen Recall Couldn’t Come at a Worse Time - Fortune Mon, 03 Apr 2017 07
- The EpiPen Alternative That Costs Just $10 - Consumer Reports Fri, 03 Feb 2017 08
- EpiPen competitor Auvi-Q comes back Feb. 14 with a pricing scheme that will blow your mind - CNBC hu, 19 Jan 2017 08
Insider Transactions
No recent insider transactions.
Financials
| Line Item | Trend | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|
| Total Revenue |
|
40.72
+102.18%
|
20.14
+72.61%
|
11.67
|
| Operating Revenue |
|
40.72
+102.18%
|
20.14
+72.61%
|
11.67
|
| Cost Of Revenue |
|
32.89
+104.28%
|
16.10
+112.72%
|
7.57
|
| Reconciled Cost Of Revenue |
|
32.89
+104.28%
|
16.10
+112.72%
|
7.57
|
| Gross Profit |
|
7.83
+93.81%
|
4.04
-1.47%
|
4.10
|
| Operating Expense |
|
20.92
+38.34%
|
15.12
+32.72%
|
11.40
|
| Research And Development |
|
0.55
+73.02%
|
0.32
+497.60%
|
0.05
|
| Selling General And Administration |
|
20.37
+37.60%
|
14.80
+30.53%
|
11.34
|
| Total Expenses |
|
53.81
+72.34%
|
31.22
+64.65%
|
18.96
|
| Operating Income |
|
-13.10
-18.14%
|
-11.08
-51.92%
|
-7.30
|
| Total Operating Income As Reported |
|
-19.57
-8.25%
|
-18.08
-147.75%
|
-7.30
|
| EBITDA |
|
-7.42
+43.26%
|
-13.08
-121.69%
|
-5.90
|
| Normalized EBITDA |
|
-8.79
-15.62%
|
-7.60
-33.66%
|
-5.69
|
| Reconciled Depreciation |
|
4.04
+26.06%
|
3.21
+102.60%
|
1.58
|
| EBIT |
|
-11.46
+29.62%
|
-16.28
-117.65%
|
-7.48
|
| Total Unusual Items |
|
1.37
+125.06%
|
-5.47
-2503.19%
|
-0.21
|
| Total Unusual Items Excluding Goodwill |
|
1.37
+125.06%
|
-5.47
-2503.19%
|
-0.21
|
| Special Income Charges |
|
1.37
+124.74%
|
-5.53
-1896.25%
|
-0.28
|
| Other Special Charges |
|
-0.80
|
—
|
-0.30
|
| Impairment Of Capital Assets |
|
6.47
-7.43%
|
6.99
|
0.00
|
| Restructuring And Mergern Acquisition |
|
-7.05
-382.60%
|
-1.46
-354.36%
|
0.57
|
| Net Income |
|
-13.20
+20.34%
|
-16.58
-124.28%
|
-7.39
|
| Pretax Income |
|
-13.20
+20.34%
|
-16.58
-121.53%
|
-7.48
|
| Net Non Operating Interest Income Expense |
|
-1.74
-499.98%
|
-0.29
|
0.00
|
| Interest Expense Non Operating |
|
1.74
+499.98%
|
0.29
|
0.00
|
| Net Interest Income |
|
-1.74
-499.98%
|
-0.29
|
0.00
|
| Interest Expense |
|
1.74
+499.98%
|
0.29
|
0.00
|
| Other Income Expense |
|
1.63
+131.42%
|
-5.20
-2704.16%
|
-0.19
|
| Other Non Operating Income Expenses |
|
0.26
-4.70%
|
0.27
+1004.76%
|
0.02
|
| Gain On Sale Of Security |
|
0.00
-95.30%
|
0.06
-12.84%
|
0.07
|
| Tax Provision |
|
0.00
|
0.00
+100.00%
|
-0.09
|
| Tax Rate For Calcs |
|
0.00
|
0.00
-100.00%
|
0.00
|
| Tax Effect Of Unusual Items |
|
0.00
|
0.00
+100.00%
|
-0.00
|
| Net Income Including Noncontrolling Interests |
|
-13.20
+20.34%
|
-16.58
-124.28%
|
-7.39
|
| Net Income From Continuing Operation Net Minority Interest |
|
-13.20
+20.34%
|
-16.58
-124.28%
|
-7.39
|
| Net Income From Continuing And Discontinued Operation |
|
-13.20
+20.34%
|
-16.58
-124.28%
|
-7.39
|
| Net Income Continuous Operations |
|
-13.20
+20.34%
|
-16.58
-124.28%
|
-7.39
|
| Normalized Income |
|
-14.58
-31.31%
|
-11.10
-54.55%
|
-7.18
|
| Net Income Common Stockholders |
|
-14.82
+17.76%
|
-18.02
-125.47%
|
-7.99
|
| Diluted EPS |
|
—
|
-176.64
-64.32%
|
-107.50
|
| Basic EPS |
|
—
|
-176.64
-64.32%
|
-107.50
|
| Basic Average Shares |
|
—
|
0.10
+37.55%
|
0.07
|
| Diluted Average Shares |
|
—
|
0.10
+37.55%
|
0.07
|
| Diluted NI Availto Com Stockholders |
|
-14.82
+17.76%
|
-18.02
-125.47%
|
-7.99
|
| Preferred Stock Dividends |
|
1.62
+11.73%
|
1.45
+140.00%
|
0.60
|
| Line Item | Trend | 2023-12-31 | 2022-12-31 |
|---|---|---|---|
| Total Assets |
|
58.39
+78.40%
|
32.73
|
| Current Assets |
|
17.02
+38.18%
|
12.32
|
| Cash Cash Equivalents And Short Term Investments |
|
1.13
-58.64%
|
2.73
|
| Cash And Cash Equivalents |
|
1.13
-58.64%
|
2.73
|
| Receivables |
|
7.19
+155.31%
|
2.82
|
| Accounts Receivable |
|
3.90
+158.26%
|
1.51
|
| Gross Accounts Receivable |
|
4.23
+173.98%
|
1.54
|
| Allowance For Doubtful Accounts Receivable |
|
-0.33
-851.43%
|
-0.04
|
| Other Receivables |
|
3.29
+151.91%
|
1.31
|
| Inventory |
|
7.17
+30.19%
|
5.51
|
| Raw Materials |
|
3.43
-1.48%
|
3.49
|
| Finished Goods |
|
4.55
+115.35%
|
2.11
|
| Prepaid Assets |
|
0.45
+498.28%
|
0.08
|
| Restricted Cash |
|
—
|
0.00
|
| Other Current Assets |
|
1.08
-8.76%
|
1.19
|
| Total Non Current Assets |
|
41.36
+102.69%
|
20.41
|
| Net PPE |
|
4.36
-15.89%
|
5.18
|
| Gross PPE |
|
5.11
-8.42%
|
5.58
|
| Accumulated Depreciation |
|
-0.76
-87.41%
|
-0.40
|
| Properties |
|
0.00
|
0.00
|
| Machinery Furniture Equipment |
|
1.89
+28.87%
|
1.47
|
| Other Properties |
|
2.98
-26.37%
|
4.04
|
| Leases |
|
0.24
+255.10%
|
0.07
|
| Goodwill And Other Intangible Assets |
|
36.95
+145.05%
|
15.08
|
| Goodwill |
|
14.65
+293.71%
|
3.72
|
| Other Intangible Assets |
|
22.29
+96.33%
|
11.35
|
| Other Non Current Assets |
|
0.06
-59.80%
|
0.15
|
| Total Liabilities Net Minority Interest |
|
33.50
+116.24%
|
15.49
|
| Current Liabilities |
|
27.87
+141.90%
|
11.52
|
| Payables And Accrued Expenses |
|
9.16
+207.03%
|
2.98
|
| Payables |
|
—
|
2.98
|
| Accounts Payable |
|
—
|
2.98
|
| Total Tax Payable |
|
—
|
—
|
| Income Tax Payable |
|
—
|
—
|
| Current Debt And Capital Lease Obligation |
|
2.58
-32.17%
|
3.80
|
| Current Debt |
|
0.49
-76.63%
|
2.10
|
| Other Current Borrowings |
|
0.49
-76.63%
|
2.10
|
| Current Capital Lease Obligation |
|
2.09
+22.70%
|
1.70
|
| Current Deferred Liabilities |
|
6.37
+34.70%
|
4.73
|
| Current Deferred Revenue |
|
6.37
+34.70%
|
4.73
|
| Other Current Liabilities |
|
9.77
+97679.29%
|
0.01
|
| Total Non Current Liabilities Net Minority Interest |
|
5.63
+41.79%
|
3.97
|
| Long Term Debt And Capital Lease Obligation |
|
5.63
+41.79%
|
3.97
|
| Long Term Debt |
|
4.10
+435.21%
|
0.77
|
| Long Term Capital Lease Obligation |
|
1.54
-52.09%
|
3.21
|
| Stockholders Equity |
|
24.88
+44.39%
|
17.23
|
| Common Stock Equity |
|
20.11
+16.67%
|
17.23
|
| Capital Stock |
|
4.78
+7129322.39%
|
0.00
|
| Common Stock |
|
0.00
+1427.27%
|
0.00
|
| Preferred Stock |
|
4.78
+8529444.64%
|
0.00
|
| Share Issued |
|
1.68
+1421.83%
|
0.11
|
| Ordinary Shares Number |
|
1.68
+1433.62%
|
0.11
|
| Treasury Shares Number |
|
0.00
+0.11%
|
0.00
|
| Additional Paid In Capital |
|
63.32
+38.79%
|
45.62
|
| Retained Earnings |
|
-43.06
-52.49%
|
-28.24
|
| Treasury Stock |
|
0.15
+0.00%
|
0.15
|
| Total Equity Gross Minority Interest |
|
24.88
+44.39%
|
17.23
|
| Total Capitalization |
|
28.98
+61.00%
|
18.00
|
| Working Capital |
|
-10.85
-1458.73%
|
0.80
|
| Invested Capital |
|
24.69
+22.86%
|
20.10
|
| Total Debt |
|
8.21
+5.63%
|
7.77
|
| Net Debt |
|
3.45
+2570.90%
|
0.13
|
| Capital Lease Obligations |
|
3.62
-26.17%
|
4.91
|
| Net Tangible Assets |
|
-12.06
-659.11%
|
2.16
|
| Tangible Book Value |
|
-16.84
-880.53%
|
2.16
|
| Inventories Adjustments Allowances |
|
-0.81
-820.59%
|
-0.09
|
| Preferred Shares Number |
|
0.55
+0.00%
|
0.55
|
| Preferred Stock Equity |
|
4.78
+8529444.64%
|
0.00
|
| Line Item | Trend | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|
| Operating Cash Flow |
|
-8.22
+5.94%
|
-8.74
-24.84%
|
-7.00
|
| Cash Flow From Continuing Operating Activities |
|
-8.22
+5.94%
|
-8.74
-24.84%
|
-7.00
|
| Net Income From Continuing Operations |
|
-13.20
+20.34%
|
-16.58
-124.28%
|
-7.39
|
| Depreciation Amortization Depletion |
|
4.04
+26.06%
|
3.21
+102.60%
|
1.58
|
| Depreciation |
|
4.04
+26.06%
|
3.21
+102.60%
|
1.58
|
| Depreciation And Amortization |
|
4.04
+26.06%
|
3.21
+102.60%
|
1.58
|
| Other Non Cash Items |
|
-7.19
-198.61%
|
-2.41
-519.39%
|
0.57
|
| Stock Based Compensation |
|
0.72
-0.26%
|
0.72
-53.52%
|
1.55
|
| Provisionand Write Offof Assets |
|
0.89
+1994.66%
|
0.04
+130.36%
|
-0.14
|
| Asset Impairment Charge |
|
6.47
-7.43%
|
6.99
+9948.99%
|
-0.07
|
| Operating Gains Losses |
|
-1.07
-1731.91%
|
-0.06
+84.81%
|
-0.38
|
| Gain Loss On Investment Securities |
|
-0.00
+95.30%
|
-0.06
+12.84%
|
-0.07
|
| Change In Working Capital |
|
1.12
+270.29%
|
-0.66
+75.83%
|
-2.72
|
| Change In Receivables |
|
-2.54
-129.85%
|
-1.11
-1610.83%
|
0.07
|
| Changes In Account Receivables |
|
-1.09
-5591.51%
|
0.02
-72.88%
|
0.07
|
| Change In Inventory |
|
1.90
+152.22%
|
-3.63
-2086.93%
|
-0.17
|
| Change In Prepaid Assets |
|
0.95
+103.28%
|
0.47
+151.07%
|
-0.92
|
| Change In Payables And Accrued Expense |
|
1.47
+38.47%
|
1.06
+298.24%
|
-0.54
|
| Change In Payable |
|
1.47
+38.47%
|
1.06
+298.24%
|
-0.54
|
| Change In Account Payable |
|
1.84
+37.40%
|
1.34
+470.79%
|
-0.36
|
| Change In Other Working Capital |
|
-0.66
-125.73%
|
2.55
+568.76%
|
-0.54
|
| Change In Other Current Liabilities |
|
—
|
-1.17
-85.79%
|
-0.63
|
| Investing Cash Flow |
|
-4.84
-2646.55%
|
-0.18
+98.79%
|
-14.59
|
| Cash Flow From Continuing Investing Activities |
|
-4.84
-2646.55%
|
-0.18
+98.79%
|
-14.59
|
| Net PPE Purchase And Sale |
|
-0.48
-1997.96%
|
-0.02
-56.21%
|
-0.01
|
| Purchase Of PPE |
|
-0.48
-1997.96%
|
-0.02
-56.21%
|
-0.01
|
| Capital Expenditure |
|
-0.56
-2261.45%
|
-0.02
+18.75%
|
-0.03
|
| Net Business Purchase And Sale |
|
-4.12
-41156990.00%
|
-0.00
+100.00%
|
-14.56
|
| Purchase Of Business |
|
-4.12
-41156990.00%
|
-0.00
+100.00%
|
-14.56
|
| Net Intangibles Purchase And Sale |
|
-0.08
-11154.11%
|
-0.00
+95.28%
|
-0.01
|
| Purchase Of Intangibles |
|
-0.08
-11154.11%
|
-0.00
+95.28%
|
-0.01
|
| Net Other Investing Changes |
|
-0.17
-8.97%
|
-0.15
|
—
|
| Financing Cash Flow |
|
11.46
+297.90%
|
2.88
-84.52%
|
18.60
|
| Cash Flow From Continuing Financing Activities |
|
11.46
+297.90%
|
2.88
-84.52%
|
18.60
|
| Net Issuance Payments Of Debt |
|
0.60
-75.58%
|
2.46
+3500.74%
|
-0.07
|
| Issuance Of Debt |
|
0.64
-73.96%
|
2.46
|
0.00
|
| Repayment Of Debt |
|
-0.04
-527.81%
|
-0.01
+90.87%
|
-0.07
|
| Long Term Debt Issuance |
|
0.44
-82.09%
|
2.46
|
0.00
|
| Long Term Debt Payments |
|
-0.04
-527.81%
|
-0.01
+90.87%
|
-0.07
|
| Net Long Term Debt Issuance |
|
0.40
-83.72%
|
2.46
+3500.74%
|
-0.07
|
| Short Term Debt Issuance |
|
0.20
|
0.00
|
—
|
| Net Short Term Debt Issuance |
|
0.20
|
0.00
|
—
|
| Net Common Stock Issuance |
|
11.63
+520.99%
|
1.87
-90.29%
|
19.27
|
| Common Stock Payments |
|
0.00
+100.00%
|
-0.15
|
0.00
|
| Cash Dividends Paid |
|
-0.77
+46.90%
|
-1.45
-140.00%
|
-0.60
|
| Repurchase Of Capital Stock |
|
0.00
+100.00%
|
-0.15
|
0.00
|
| Proceeds From Stock Option Exercised |
|
—
|
0.00
-100.00%
|
0.00
|
| Changes In Cash |
|
-1.60
+73.42%
|
-6.03
-101.81%
|
-2.99
|
| Beginning Cash Position |
|
2.73
-68.81%
|
8.77
-25.43%
|
11.76
|
| End Cash Position |
|
1.13
-58.64%
|
2.73
-68.81%
|
8.77
|
| Free Cash Flow |
|
-8.78
-0.19%
|
-8.76
-24.66%
|
-7.03
|
| Interest Paid Supplemental Data |
|
0.82
+1318.75%
|
0.06
+5529.55%
|
0.00
|
| Income Tax Paid Supplemental Data |
|
—
|
0.00
-100.00%
|
0.02
|
| Change In Income Tax Payable |
|
—
|
0.00
+100.00%
|
-0.17
|
| Change In Tax Payable |
|
—
|
0.00
+100.00%
|
-0.17
|
| Common Stock Issuance |
|
11.63
+475.01%
|
2.02
-89.51%
|
19.27
|
| Issuance Of Capital Stock |
|
11.63
+475.01%
|
2.02
-89.51%
|
19.27
|
| Preferred Stock Dividend Paid |
|
-0.77
+46.90%
|
-1.45
-140.00%
|
-0.60
|
SEC Filings
No SEC filings found for this symbol (may be non-US or ticker not in SEC index).
Trades
| Date | User | Broker | Pattern | Type | Position Size | Entry Price | Trade P&L | Status |
|---|
Posts
| Published | Title | Author | Category |
|---|